House Democrats Hammer On Arguments Against FDA Pre-Emption
This article was originally published in The Gray Sheet
Executive Summary
A Supreme Court ruling favoring federal pre-emption for PMA-approved devices will shift the financial burden of faulty devices from manufacturers to U.S. consumers and taxpayers, Congressional Democrats argue